India’s 1st mRNA Covid-19 vaccine likely to be Available Soon

June 28, 2022
Current Context: The Subject Expert Committee recommended Emergency Use Authorisation for India's first mRNA COVID-19 vaccine.
India’s 1st mRNA Covid-19 vaccine likely to be Available Soon
  • Besides the Drugs controller general of India (DCGI) is expected to give Emergency Use Authorisation to Gennova’s mRNA vaccine.
  • The vaccine - GEMCOVAC-19 - is the country's first homegrown mRNA COVID- 19 vaccine and is seen as a game-changer for the healthcare industry.
  • The company has conducted phase 2 and phase 3 data trials on 4000 participants to evaluate vaccine safety, immunogenicity, and tolerability.
  • mRNA vaccines use mRNA to teach our cells how to make a protein or a protein that triggers an immune response inside our bodies.
  • It is based on the Moderna model but has been built with the information available in the open and indigenous technology and materials.

Question:

Q.1 Which of the following is the first Homegrown mRNA COVID-19 vaccine in India?
a. Moderna
b. Covaxin
c. Cansino
d. GEMCOVAC-19

Free Exam Resources

Useful material to support your preparation, revision and exam planning.

Continue on BankExamsToday

Revise notes, practice questions and resume anytime.

Meet your mentor

From the Founder

Ramandeep Singh, founder of BankExamsToday

Ramandeep Singh

Banking Educator · Former Banker

Former banker and educator helping aspirants prepare for banking promotion and specialist officer exams with focused, practical guidance.

14+
Years' experience
5,000+
Selections
Ex-BoB
Banking experience